COVID-19 does not influence functional status after ARDS therapy

Table 2 Risk factors for high disability* after 180 days (univariate analysis using binary logistic regression after multiple imputation) (n = 144)

	OR	95% CI	P
Variables at baseline assessment
Gender
Male	1
Female	0.42	0.19–0.91	0.031
Age in years	1.04	1.01–1.07	0.021
BMI	0.97	0.91–1.04	0.43
Diabetes yes	0.71	0.29–1.72	0.45
Pulmonary diseases yes	1.04	0.38–2.81	0.94
HTA yes	0.92	0.44–1.94	0.84
Min PaO₂/FiO₂	0.99	0.99–1.001	0.132
Max PaO₂/FiO₂	0.996	0.99–1.000	0.059
SOFA baseline	1.12	0.99–1.26	0.064
COVID-19	0.94	0.38–2.33	0.89
Variables during the follow-up
SOFA 5 days ICU	1.17	1.06–1.30	0.003
ECMO yes	2.51	1.02–6.18	0.047
Acute Kidney Insufficiency yes	2.50	1.07–5.82	0.036
CRRT yes	2.79	1.14–6.81	0.026
Any infection yes	0.63	0.18–2.23	0.48
Viral infection yes	0.84	0.33–2.11	0.71
Therapy
NaCl	1
Ilosprost	1.06	0.48–2.32	0.89
Time ICU days	1.01	0.99–1.03	0.24

CRRT continuous renal replacement therapy, ECMO extracorporeal membrane oxygenation, AKI acute kidney injury
*High disability: Barthel index 0–60

ISSN: 1364-8535